Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
Top

The Vitamin D and type 2 diabetes (D2d) study: A multicenter randomized controlled trial for diabetes prevention

print
PRINT
insite
SEARCH

Friday June 7, 11:30–12:30. Room S157, Moscone Center, San Francisco, California

  1. Rationale and study design. Myrlene A. Staten, MD
  2. Recruitment, retention, and baseline characteristics. Erin S. Leblanc, MD, MPH
  3. Outcomes. Anastassios G. Pittas, MD, MS


The D2d trial is of particular interest due to a growing body of evidence which suggests that glucose and insulin metabolism may have farther-reaching effects on health and nutrition than previously thought. There now appears to be a greater understanding as to why so many patients with type 2 diabetes have vitamin D deficiency, and we need to determine if it's causative or as a result of insulin resistance.


– Jay Shubrook, Primary Care Physician

More on this trial

print
PRINT